Time trends in social contacts of individuals according to comorbidity and vaccination status, before and during the COVID-19 pandemicCOVID-19 대유행 전과 동안, 동반이환 및 예방접종 상태에 따른 개인의 사회적 접촉의 시간 경향Article Published on 2022-05-232022-09-11 Journal: BMC Medicine [Category] COVID19(2023년), SARS, 변종, [키워드] 95%CI analyses Analysis booster dose booster doses Canada Christma Comorbidities Comorbidity Complication conducted Contact COVID-19 COVID-19 complications COVID-19 pandemic COVID-19 vaccination cross-sectional described distance Efficacy explained first dose First wave Generalized linear model greater Immune escape individual Infectious diseases Intervention masking medical condition medication MONITOR outcome pandemic participant performed physical contact Poisson distribution Public public health Quebec, Canada questionnaire random recruited repeated risk of COVID-19 robust second wave significant difference significantly social contact Social contacts the mean the vaccine time used data vaccination Vaccination Status Vaccine vaccine efficacy variant [DOI] 10.1186/s12916-022-02398-x PMC 바로가기 [Article Type] Article
Dealing With Immunoglobulin Shortages: A Rationalization Plan From Evidence-Based and Data Collection면역글로불린 부족 처리: 증거 기반 및 데이터 수집의 합리화 계획Article Published on 2022-05-192022-09-12 Journal: Frontiers in Public Health [Category] MERS, 진단, [키워드] 95% CI addition analyzed Clinical management Clinical use close monitoring Collection coronavirus disease COVID-19 decrease demonstrated Effectiveness evaluate Evidence-based medicine Evolution IgG IgGs Immunoglobulin immunogolobulins indication information initial Intervention lack managing mean difference measure Measures occurred pandemic Patient performed plan public health public health system Rationalization real-world data Regional registry retrospective second shortages statistically Support the mean therapeutic Treatment was collected [DOI] 10.3389/fpubh.2022.893770 PMC 바로가기 [Article Type] Article
Response to three doses of the Pfizer/BioNTech BNT162b2 COVID-19 vaccine: a retrospective study of a cohort of haemodialysis patients in France화이자/바이오엔텍 BNT162b2 코로나19 백신 3회 투여에 대한 반응: 프랑스 혈액투석 환자 집단에 대한 후향적 연구Observational Study Published on 2022-05-182022-09-12 Journal: BMC Nephrology [Category] COVID19(2023년), MERS, SARS, 임상, 진단, [키워드] Anti-spike blood sample BNT162b2 body mass index booster Clinical practice Cohort Comirnaty coronavirus disease COVID-19 defined dialysis dose Factor France French Haemodialysis humoral humoral immune response identify IgG Immunoglobulin injection Injections kidney mortality rate mRNA vaccine National non-responder of BNT162b2 Patient patients performed Pfizer/BioNTech receive Registered remained Responder response retrospective Retrospective study SARS-CoV-2 serological serum albumin significantly significantly higher study population the mean the median titre U/mL Vaccine vaccine doses venous [DOI] 10.1186/s12882-022-02751-5 PMC 바로가기 [Article Type] Observational Study
Tiny Habits ® for Gratitude-Implications for Healthcare Education StakeholdersRandomized Controlled Trial Published on 2022-05-162022-10-04 Journal: Frontiers in Public Health [Category] 임상, [키워드] Anxiety approach automated Burnout chose coach Control COVID-19 COVID-19 pandemic education effective gratitude greater group habit habits Health Health profession healthcare Healthcare professional healthcare professionals (HCPs) implication IMPROVE increase in Intervention participant participated physical professional Program psychological health Psychological well-being Randomized randomized study RECIPE self-care significantly Stress the mean Tiny Habits [DOI] 10.3389/fpubh.2022.866992 PMC 바로가기 [Article Type] Randomized Controlled Trial
Comparison of the effectiveness and duration of anti-RBD SARS-CoV-2 IgG antibody response between different types of vaccines: Implications for vaccine strategies다양한 유형의 백신 간의 항-RBD SARS-CoV-2 IgG 항체 반응의 효과 및 지속 기간 비교: 백신 전략에 대한 시사점Article Published on 2022-05-032022-09-12 Journal: Vaccine [Category] COVID19(2023년), MERS, SARS, 진단, [키워드] Abbott addition anti-RBD Anti-RBD antibody Anti-RBD IgG anti-RBD IgG antibody Antibody Response Antibody titer AstraZeneca Blood Blood Bank Blood bank donors, vaccine booster Booster vaccine Breakthrough infection center CMIA collected COVID-19 COVID-19 vaccines Donor donors Effectiveness Efficacy healthcare worker Healthcare workers highest Hussein IgG IgG level Johnson & Johnson Jordan King material Moderna MOST mRNA vaccine neutralizing antibody participant Pfizer Pfizer/BioNTech Protective random Re-infection recipient Sample SARS-CoV-2 SARS-CoV-2 IgG antibody SARS-CoV-2 vaccines shown significantly significantly lower Sinopharm susceptibility the mean USA vaccination Vaccine vaccine-induced antibody Vaccines were measured [DOI] 10.1016/j.vaccine.2022.03.069 PMC 바로가기 [Article Type] Article
Ruxolitinib in addition to standard of care for the treatment of patients admitted to hospital with COVID-19 (RUXCOVID): a randomised, double-blind, placebo-controlled, phase 3 trialResearch article Published on 2022-05-012022-10-05 Journal: The Lancet Rheumatology [Category] 임상, 치료법, [키워드] 95% CI acute respiratory distress addition Adverse age analysed assigned baseline benefit clinical status composite endpoint Concentration covariates COVID-19 Cytokine dysregulation Cytokine release syndrome death determine diarrhoea died disease disorder double-blind Efficacy event Exploratory analysis faster female finding funding hazard ratio headache hospital hospitalised ICU care Incyte Inflammatory cytokine inhibitor intensive care International invasive ventilation JAK1/JAK2 inhibitor Janus kinase Logistic regression male median time myelofibrosis nine Novartis occurred Odds ratio on mechanical ventilation Patient patients patients with COVID-19 per day phase 3 trial Placebo placebo-controlled primary endpoint randomised Randomly reduce Registered required Respiratory failure ruxolitinib secondary hemophagocytic lymphohistiocytosis Sex Standard of care study population subgroups the mean Treatment Trial with COVID-19 [DOI] 10.1016/S2665-9913(22)00044-3 [Article Type] Research article
Antibody response to the COVID-19 ChAdOx1nCov-19 and BNT162b vaccines after temporary suspension of DMARD therapy in immune-mediated inflammatory disease (RESCUE)면역매개염증질환(RESCUE)에서 DMARD 치료를 일시적으로 중단한 후 COVID-19 ChAdOx1nCov-19 및 BNT162b 백신에 대한 항체 반응Randomized Controlled Trial Published on 2022-05-012022-09-11 Journal: RMD Open [Category] COVID19(2023년), MERS, SARS, 임상, 진단, 치료기술, 치료제, [키워드] Adult patients Antibody Response Antibody responses antirheumatic agents AstraZeneca AZ vaccine baseline biologic BNT162b Control control group control groups controls COVID-19 csDMARD dose Final first and second dose first dose first vaccination group groups IgG Immune-mediated immunogenicity inflammatory disease Messenger RNA multicentre not significantly different Patient Pfizer Protein randomised randomised controlled trial registration number response S1/S2 SARS-CoV-2 antibody SARS-CoV-2 IgG SARS-CoV2 second dose second vaccination Seroconversion seroconversion rate seroconversion rates significantly lower the antibody response the mean therapy titre titres U/mL vaccination Vaccine were measured [DOI] 10.1136/rmdopen-2022-002301 PMC 바로가기 [Article Type] Randomized Controlled Trial
Effect of the Mindfulness-Based Stress Reduction program on stress, anxiety, and childbirth fear in pregnant women diagnosed with COVID-19Randomized Controlled Trial Published on 2022-05-012022-10-05 Journal: Complementary therapies in clinical practice [Category] 임상, [키워드] Anxiety Attitude BAI Beck Childbirth collected composed control group COVID-19 diagnosed with COVID-19 distress Effect Effectiveness eight experimental group Health IMPROVE inventory material Mental mindfulness Perinatal Perinatal mental health Pregnancy pregnant women Prenatal mood. professional provided Psychological well-being randomized-controlled reduce significantly lower Stress the mean Trial was performed [DOI] 10.1016/j.ctcp.2022.101566 PMC 바로가기 [Article Type] Randomized Controlled Trial
Automated virtual reality therapy to treat agoraphobic avoidance and distress in patients with psychosis (gameChange): a multicentre, parallel-group, single-blind, randomised, controlled trial in England with mediation and moderation analysesRandomized Controlled Trial Published on 2022-05-012022-10-05 Journal: The lancet. Psychiatry [Category] Fulltext, MERS, 임상, [키워드] 1:1 95% CI added adjusted affective age Algorithm Analysis Anxiety assigned automated avoidance block Clinical diagnosis cognitive Controlled trial COVID-19 pandemic Diagnosis disorder distress Effect effective Efficacy eight eligibility England enrolled evaluate event greater help indicated Innovation intention-to-treat population invention ISRCTN Local mean difference Mediation analysis men multicentre National Health Service nine no significant difference Occurrence Older outcomes Oxford parallel-group participant Patient patients performed primary endpoint Primary outcome Protective behaviours provided psychological therapy randomisation randomised Randomly recruitment reducing reduction reductions in Registered scale Schizophrenia Serious Adverse Event Seven severity single-blind stratified study group Symptoms the mean therapy thought Transport treat Treatment Trial usual care usual care alone were assessed white women [DOI] 10.1016/S2215-0366(22)00060-8 PMC 바로가기 [Article Type] Randomized Controlled Trial
The role of Monocyte Distribution Width (MDW) in the prognosis and monitoring of COVID-19 patientsCOVID-19 환자의 예후 및 모니터링에서 단핵구 분포 폭(MDW)의 역할Article Published on 2022-05-012022-09-11 Journal: Clinical biochemistry [Category] COVID19(2023년), MERS, SARS, 바이오마커, 진단, [키워드] age AUC Beckman Coulter blood count blood sample calculated complete blood count correlated COVID-19 COVID-19 patient COVID-19 patients Critically ill Critically ill patient critically ill patients cut-off diagnostic distribution Efficacy enrolled form hospitalisation ICU less monocyte Monocyte Distribution Width (MDW) non-survivor not significant outcome parameter Patient patients procalcitonin Prognosis prognostic reported SARS-CoV-2-positive patient Sensitivity and specificity severe forms of COVID-19 shown significantly Standard deviation Support Surveillance Survivors the mean unfavourable prognosis was used width [DOI] 10.1016/j.clinbiochem.2022.02.007 PMC 바로가기 [Article Type] Article